Vitrolife ABOSTO:VITR +0.69%78 Days Inventory is 118.43 as of Mar. 2026, which is 12% below its 10-year median of 135.26. GuruFocus rates OSTO:VITR with a GF Score™ of 78/100 and a GF Value™ of kr162.48 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Vitrolife AB ranks better than 77.66% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Vitrolife AB's Average Total Inventories for the
three
months ended in Mar. 2026 was kr421 Mil. Vitrolife AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was kr324 Mil.
Hence, Vitrolife AB's Days Inventory for the
three
months ended in Mar. 2026 was 118.43.
The historical rank and industry rank for Vitrolife AB's Days Inventory or its related term are showing as below:
OSTO:VITR'
s Days Inventory Range Over the Past 10 Years
Min: 90.12 Med: 135.26 Max: 157.66
Current: 109.58
During the past 13 years, Vitrolife AB's highest Days Inventory was 157.66. The lowest was 90.12. And the median was 135.26.
OSTO:VITR's Days Inventory is ranked better than 77.66% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs OSTO:VITR: 109.58
Vitrolife AB's Days Inventory
increased
from Mar. 2025 (106.12) to Mar. 2026 (118.43).
It might indicate that Vitrolife AB's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vitrolife AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.77.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vitrolife AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.52.
Vitrolife AB (OSTO:VITR) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vitrolife AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vitrolife AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vitrolife AB Days Inventory Related Terms
Vitrolife AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Vitrolife AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:VITR vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Vitrolife AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitrolife AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vitrolife AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitrolife AB (OSTO:VITR) has a Days Inventory of 118.43 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vitrolife AB and its competitors. This is 12% below median its historical median of 135.26. Over the past decade, Vitrolife AB's Days Inventory has ranged from 90.12 to 157.66. According to the industry distribution chart, Vitrolife AB ranks #176 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 22.3%.
Is Vitrolife AB's Days Inventory too high?
Vitrolife AB's current Days Inventory of 118.43 is 12% below median its 10-year median of 135.26. Over the past 10 years, this metric has ranged from a low of 90.12 to a high of 157.66. The Medical Devices & Instruments industry median Days Inventory is 179.12. Vitrolife AB's value of 118.43 is 33.9% below this industry median. Based on the distribution chart, Vitrolife AB ranks #176 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Vitrolife AB has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vitrolife AB ranks #176 out of 788 companies for Days Inventory. This places Vitrolife AB in the top 22% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.12. Vitrolife AB's value of 118.43 is 33.9% below this benchmark. Historically, Vitrolife AB's own Days Inventory has ranged from 90.12 to 157.66 over the past decade. While the company's 10-year median is 135.26 vs. the industry median of 179.12, Vitrolife AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitrolife AB's current Days Inventory of 118.43 is 33.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vitrolife AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitrolife AB's current Days Inventory is 118.43, which is 12% below median its own 10-year median of 135.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Based on GuruFocus' analysis, Vitrolife AB (OSTO:VITR) is currently considered Possible Value Trap. The stock's GF Value™ is kr162.48, compared to a current price of kr87.00 — trading 46.5% below its estimated fair value. The current Days Inventory is 118.43, which is 12% below median its 10-year median of 135.26 and 33.9% below the Medical Devices & Instruments industry median of 179.12. Vitrolife AB's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vitrolife AB (OSTO:VITR), the current Days Inventory is 118.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vitrolife AB (OSTO:VITR) Overvalued in 2026?
Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued.
The current stock price of kr87.00 is trading 46.5% below its estimated GF Value™ of kr162.48.
GuruFocus considers Vitrolife AB to be Possible Value Trap.
Key valuation signals for OSTO:VITR:
Days Inventory: 118.43 (12% below median its 10-year median of 135.26)
GF Value™: kr162.48 vs. price of kr87.00 (46.5% below fair value)
Industry Position: 33.9% below the Medical Devices & Instruments median (#176 of 788)
No single metric tells the full story. See the OSTO:VITR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
78GF Score
Get the complete analysis for OSTO:VITR
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:VITR has been successfully added to your 
